This compound is a chemical intermediate specifically employed in the industrial synthesis of the fluoroquinolone antibiotic levofloxacin. It is characterized by a polycyclic structure containing fluorine and piperazine functional groups, which are key to its role in pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 177472-30-9
Ethyl (S)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylate
pharmaceutical intermediate
2-Amino-5-nitrobenzophenone
pharmaceutical intermediate
Tert-Butyl (trans-4-aminomethylcyclohexyl)carbamate
pharmaceutical intermediate
5-Methylindazole
pharmaceutical intermediate
4-Aminocyclohexanecarboxylic acid
pharmaceutical intermediate
DL-ofloxacin
pharmaceutical raw material
Ofloxacin
pharmaceutical raw material
Levofloxacin
pharmaceutical raw material
ethyl 7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylate
OEHYGCZCGGEXKX-UHFFFAOYSA-N
CCOC(=O)C1=CN2C(COC3=C2C(=CC(=C3N4CCN(CC4)C)F)C1=O)C